Lakefront Biotherapeutics N.V. (LKFT) quarterly cash flow statement — complete operating, investing & financing history
Lakefront Biotherapeutics N.V. (LKFT) cash flow statement — 22-year operating, investing & financing cash flows
| Metric | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 |
|---|
| Cash from Operations | -32.92M | 0 | -82.75M | -47.46M | -62.61M | -108.78M | - | - | - | - | - | -66.87M | -118.82M | -125.42M | -94.87M | -178.78M | -116.94M | -141.77M | -61.97M | -163.77M |
| Operating CF Margin % | -436.97% | - | -1276.81% | -5.27% | -87.98% | -166.62% | - | - | - | - | - | 31.97% | -98.99% | -83.64% | -161.96% | -187.95% | -85.86% | -103.02% | -45.45% | -98.07% |
| Operating CF Growth % | 47.42% | 100% | - | - | - | - | - | - | - | - | - | 62.6% | -1.6% | 11.53% | -53.09% | -9.17% | 14.59% | -73.06% | 48.87% | -340.64% |
| Net Income | -8.24M | 2.11M | 14.49M | 782.15M | -202.11M | -105.75M | - | - | - | - | - | 157.56M | 25.83M | 5.1M | 23.21M | -211.36M | 21.55M | -19.03M | -13.31M | 16.35M |
| Depreciation & Amortization | 0 | 3.04M | 0 | 0 | 0 | 0 | - | - | - | - | - | 0 | -18.57M | 18.57M | 0 | 22.15M | 5.88M | 32.46M | 5.52M | 5.59M |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | 0 | -27.59M | 27.59M | 0 | 0 | 18.92M | 17.77M | 14.4M | 7.75M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | 0 | 0 | 0 | 0 | -1.28M | 693K | 0 | 0 | 0 |
| Other Non-Cash Items | -22.01M | -5.15M | -61.8M | -15.82M | 197.33M | 54.18M | - | - | - | - | - | 58.42M | -66.71M | -149.86M | 24.17M | 88.78M | -66.69M | -66.88M | -11.27M | -12.09M |
| Working Capital Changes | -2.67M | 0 | -35.44M | -813.79M | -57.83M | -57.21M | - | - | - | - | - | -282.85M | -31.78M | -26.82M | -142.24M | -77.06M | -97.3M | -106.09M | -57.31M | -181.37M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | 0 | 14.55M | -14.55M | 0 | 4.34M | 10.3M | 11.32M | 41.89M | -2.15M |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | 0 | -3.14M | 3.14M | 0 | -30.04M | 4.53M | -11.2M | 1.01M | -19.11M |
| Change in Payables | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | 0 | 0 | 0 | 0 | -1.79M | 0 | 0 | 0 | 0 |
| Cash from Investing | 29.76M | 0 | 61.5M | 72.62M | 56.74M | 74.71M | - | - | - | - | - | 76.41M | 182.54M | 100.91M | -288.67M | 44.39M | -182.57M | -147.6M | -933.45M | -451.95M |
| Capital Expenditures | -150.84K | 0 | -123K | -1.6M | -2.85M | -4.16M | - | - | - | - | - | -7.98M | -3.01M | -3.8M | -4.26M | -7.54M | -4.23M | -6.4M | -9.18M | -20.3M |
| CapEx % of Revenue | 2% | - | 1.9% | 0.18% | 4% | 6.36% | - | - | - | - | - | -3.82% | 2.51% | 2.53% | 7.28% | 7.92% | 3.11% | 4.65% | 6.73% | 12.16% |
| Acquisitions | -459.49K | 0 | 2.34M | 1.62M | 8.08M | -22.19M | - | - | - | - | - | -7M | 0 | 0 | 0 | 2.5M | -92K | -115.18M | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 1.04M | 0 | 1.32M | 5.46M | 13.11M | 23.84M | - | - | - | - | - | 5.03M | 185.55M | 104.71M | -21K | 216.61K | -5.83M | -11.09M | -487K | -2.01M |
| Cash from Financing | -38.62M | 0 | -510K | -405K | -1.26M | -600K | - | - | - | - | - | -1.19M | -2.07M | -1.55M | -190K | -2.01M | 793K | -336K | -25K | -1.44M |
| Debt Issued (Net) | 0 | 0 | -510K | -405K | -1.26M | -600K | - | - | - | - | - | -1.19M | -2.07M | -1.55M | -1.96M | 0 | -2.28M | -1.8M | -2.18M | -2.02M |
| Equity Issued (Net) | -38.06M | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | 0 | 0 | 0 | 0 | -145.02K | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | -38.06M | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -558.73K | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | 0 | 0 | 0 | 1.77M | -1.87M | 3.08M | 1.46M | 2.16M | 578K |
| Net Change in Cash | -41.4M | -66.81M | -21.06M | 23.41M | -7.21M | -36.4M | - | - | - | - | - | 7.44M | 61.35M | -26.11M | -383.98M | 57.62M | -297.28M | -281.48M | -979.09M | -601.01M |
| Free Cash Flow | -33.07M | 0 | -82.87M | -49.06M | -65.46M | -112.94M | - | - | - | - | - | -74.84M | -121.83M | -129.22M | -99.15M | -186.26M | -128.7M | -149.46M | -71.63M | -186.08M |
| FCF Margin % | -438.98% | - | -1278.71% | -5.45% | -91.98% | -172.98% | - | - | - | - | - | 35.79% | -101.5% | -86.17% | -169.28% | -195.82% | -94.49% | -108.61% | -52.54% | -111.43% |
| FCF Growth % | 49.48% | 100% | - | - | - | - | - | - | - | - | - | 59.82% | 5.34% | 13.54% | -38.41% | -0.1% | 15.57% | -60.28% | 44.87% | -124.14% |
| FCF per Share | -0.50 | - | -1.26 | -0.74 | -0.99 | -1.71 | - | - | - | - | - | -1.13 | -1.85 | -1.96 | -1.50 | -2.83 | -1.95 | -2.27 | -1.08 | -2.80 |
| FCF Conversion (FCF/Net Income) | 12.40x | - | -5.71x | -0.06x | 0.31x | 1.03x | - | - | - | - | - | -0.42x | -4.60x | -24.59x | -4.09x | 0.86x | -5.43x | 7.45x | 4.66x | -10.02x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | 0 | 257K | 528K | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |